A study involving 244 pigs initially averaging 13 kg was conducted at two stations to evaluate tiamulin as a growth promotant for growing swine. In each experiment, four replicate pens of five (Exp. 1) or six (Exp. 2) pigs/pen were used to evaluate each treatment. In Exp. 1, pigs were fed 0, 11, 22 or 44 ppm tiamulin from 15 to 58 kg, then fed a nonmedicated control diet for the remainder of the experiment (to 95 kg). In Exp. 2, pigs were fed 0, 2.75, 5.5, 11 or 22 ppm tiamulin from 11 to 56 kg, followed by the nonmedicated control diet (to 95 kg), In each experiment, carbadox (55 ppm) was included as a positive control and was fed to an average weight of 35 kg, followed by the control diet. Averaged across all dietary levels, tiamulin resulted in a 14.1% improvement in gain and a 5.7% improvement in feed:gain ratio during the first 28 to 35 d of the experiment (to 30 kg). These improvements were slightly less than those resulting from the feeding of carbadox during the same period (21.5 and 6.9%, respectively). From 13 to 57 kg, pigs fed tiamulin gained 11.6% faster and 3.1% more efficiently than did controls. Over the entire experiment (13 to 95 kg), tiamulin-fed pigs gained 5.7% faster than did controls, even though the tiamulin was withdrawn at 57 kg body weight. Growth rate from 13 to 57 kg plateaued at the 11-ppm dietary level of tiamulin; whereas, feed:gain ratio plateaued at the 22-ppm level. The results indicate that tiamulin is an effective growth promotant for growing swine.
Introduction
Tiamulin hydroge n fumarate [14-deoxy-14(2-diethylaminoethyl) mercaptoacetoxy mutilin hydrogen fumerate]is a semi-synthetic derivative of the antibiotic, pleuromutilin (Egger and Reinshagen, 1976a,b) . Tiamulin is active in vitro and in vivo against pathogenic mycoplasma organisms, Treponema hyodysenteriae, a large number of gram-positive organisms (streptococci, staphylococci) and some gram-negative organisms (Shigella, Klebsiella and E. coli; Drews et al., 1975) .
Tiamulin is used in about 40 countries for dysentery and pneumonia control in swine and for airacculitis control in poultry , but is not cleared for use in the USA. O'Connor et al. (1979) reported that dietary levels of 33 to 44 ppm of tiamulin were effective in preventing the development of dysentery in pigs infected with T. hyodysenteriae. These researchers also found that a combination of tiamulin at 22 to 55 ppm and sulfamethazine at 110 ppm improved growth rate in noninfected pi~.
This research was conducted to evaluate the efficacy of tiamulin as a growth promotant for growing pigs.
Experimental Procedure
A total of 244 pigs were used in the study. Trials were conducted at the University of Kentucky (Exp. 1) and at a commercial research farm in Kansas (Exp. 2). In both trials, pigs were allotted to treatments from outcome groups based on initial weight and sex. There were four replicate pens of five (Exp. dprovided (mg/kg of starter and grower diet): Zn, 100; Fe, 100; Mn, 100; Cu, 10; Co, 1; I, 3. These levels were reduced by one-half in finisher diet. eprovided per kg of diet: vitamin A, 4,400 IU; vitamin D3, 660 IU; vitamin E, 22 IU riboflavin, 17.6 mg; pantothenic acid, 35.0 rag; niacin, 53 mg; vitamin B12 , 22 pg choline chloride, 176 mg. Levels of riboflavin, niacin, pantothenic acid and choline were reduced by one-half in grower and finisher diets.
was Hampshire-Yorkshire (Exp. 1) or Yorkshire-Duroc (Exp. 2).
Pigs were housed in open-front, concretefloored pens in both experiments. The basal diet consisted of corn (Exp. 1) or grain sorghum (Exp. 2) and soybean meal, and was fortified with sufficient levels of vitamins and minerals to meet NRC (1979) weighings. Average final weight was 95 kg at each location. In Exp. 1, tiamulin 4 was added to the basal diet at levels of 0, 11, 22 and 44 ppm. These levels were fed for 65 d (average weight, 58 kg), after which the nonmedicated basal diet was fed until the end of the experiment (average weight, 95 kg). A fifth treatment was carbadox s added to the basal diet at 55 ppm, which served as a positive control. After 35 d (average weight 35 kg), the carbadox was removed and the basal diet was fed until the end of the experiment.
In Exp. 2, tiamulin was included at levels of 0, 2.75, 5.5, 11 and 22 ppm. These levels were fed for 73 d (average weight, 56 kg), after which the basal diet was fed until the end of the experiment (average weight, 95 kg). A sixth treatment was carbadox (55 ppm) fed until pigs reached 35 kg body weight, followed by the nonmedicated control diet.
The data were analyzed by variance procedures (Steel and Torrie, 1960 ) using the Sta-tistical Analysis System (SAS, 1979) . The pen was considered as the experimental unit. The data also were pooled and analyzed as an incomplete block. Breakpoint analysis of the pooled data was used to estimate the level of tiamulin that maximized rate and efficiency of gain (Anderson and Nelson, 1975) .
Results and Discussion
Exp. I. The addition of tiamulin to the diet resulted in linear improvements in growth rate (P<.01) and feed/gain (P<.05) in the weight range of 15 to 35 kg body weight (table  2) . From 15 to 58 kg, the improvement in daily gain from the feeding of tiamulin was quadratic (P<.05), while the improvement in feed:gain ratio was linear (P<.05). Even though tiamulin was withdrawn at 58 kg, pigs in the tiamulintreatment groups gained faster (P<.05) over the entire experimental period. Feed/gain responses were not different (P>.10) among treatment groups over the entire test period.
Exp. 2. During the initial 28 d (11 to 24 kg body weight), linear improvements (P<.01) in growth rate and feed:gain ratio occurred with increasing levels of tiamulin in the diet (table  3) . From 11 to 56 kg body weight, growth rate and feed/gain responses increased quadratically (P<.05) with increasing levels of tiamulin. At the end of the trial (126 d), the growth and feed/gain advantage resulting from the initial feeding of tiamulin was maintained, in that a quadratic response to tiamulin addition occurred for both gain and feed:gain ratio (P<.10).
Pooled Data. The treatment means (adjusted for missing cells) of the pooled data of Exp. 1 and 2 were subjected to breakpoint analysis in order to determine the most efficacious level of tiamulin. During the period that tiamulin was fed (13 to 57 kg), growth rate tended to plateau at the 11-ppm level of tiamulin, whereas feed/gain tended to plateau at the 22-ppm level (figure 1). Over the entire duration of the test (13 to 95 kg), the breakpoint for growth rate was at 5.5 ppm tiamulin; however, the feed/gain responses failed to plateau with increasing levels of tiamulin.
During the initial 28 to 35 d of the test, pigs fed tiamulin (averaged across all levels) gained 14.1% faster and 5.7% more efficiently (P<.01) fQuadratie effect (P<.10).
and those fed carbadox gained 21.5% faster and 6.9% more efficiently (P<.01) compared with pigs fed the nonmedicated control diet (table  4) . There was a difference (P<.02) in growth rate between the carbadox and the tiamulin groups during this period. The improvement in growth rate from antibiotics tended to be greater in the Kentucky test (Exp. 1), while the improvement in feed:gain ratio from antibiotics tended to be greater in the Kansas test (Exp. 2), but the station • treatment interaction was not significant for either trait. The magnitude of these responses to tiamulin and carbadox is similar to those reported for other antibiotics in pigs of similar weight (Hays, 1977; CAST, 1981) . At 57 kg, pigs fed tiamulin or carbadox gained 11.6 and 9.7% faster, respectively, than did controls (P<.01). At the end of the trial, pigs previously fed antibiotics maintained a growth advantage over controls (5.7 and 4.4% for tiamulin and carbadox, respectively; P<.01) even though the antibiotics had been withdrawn for an average of 38 and 65 d, respectively. Feed/gain responses were improved in the Kansas trial but not in" the Kentucky trial, resulting in a station x treatment interaction (P<.02).
The results indicate that tiamulin is an effective growth promotant in swine from 13 to 57 kg body weight. Currently, tiamulin is not cleared by the Food and Drug Administration as a growth promotant in the USA. 
